The Risk of In-Transit Melanoma Metastasis Depends on Tumor Biology and Not the Surgical Approach to Regional Lymph Nodes-Reference-Cited by-同舟云学术

The Risk of In-Transit Melanoma Metastasis Depends on Tumor Biology and Not the Surgical Approach to Regional Lymph Nodes

Published:2005-07-20 Issue:21 Volume:23 Page:4588-4590
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Pawlik Timothy M.¹,Ross Merrick I.¹,Thompson John F.¹,Eggermont Alexander M.M.¹,Gershenwald Jeffrey E.¹

Affiliation:

1. Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, The Sydney Melanoma Unit, Royal Prince Alfred Hospital, and the University of Sydney, Sydney, Australia, and the Department of Surgical Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.12.245

Reference25 articles.

1. Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma

2. Ross MI, Reintgen D, Balch CM: Selective lymphadenectomy: Emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 9:219,1993-223,

3. Lymphatic Mapping in the Molecular Era

4. Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma Patients

5. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment for Regionally Advanced and In-transit Melanoma;Melanoma;2024

2. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0;Journal for ImmunoTherapy of Cancer;2023-10

3. A safety review of recently approved and late-stage trial treatments for metastatic melanoma: systemic and regional therapies;Expert Opinion on Drug Safety;2023-08-18

4. Oncolytic intralesional therapy for metastatic melanoma;Clinical & Experimental Metastasis;2023-08-09

5. Management of In-Transit Metastatic Melanoma;Advances in Oncology;2023-05